# A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD

> **NCT00035828** · PHASE2 · COMPLETED · sponsor: **Abgenix** · enrollment: 150 (—)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive
- Bronchitis, Chronic

## Interventions

- **DRUG:** ABX-IL8

## Key facts

- **NCT ID:** NCT00035828
- **Lead sponsor:** Abgenix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 150 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00035828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00035828, "A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to Placebo in Patients With Chronic Bronchitis and COPD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00035828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*